수차측정 및 각막지형도 시스템 시장 : 규모, 점유율, 성장, 산업 분석, 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of aberrometer & topography systems Market

The global aberrometer & topography systems market was valued at USD 501.24 million in 2025 and is projected to grow to USD 528.38 million in 2026, reaching USD 836.73 million by 2034, registering a CAGR of 6.61% during the forecast period. North America led the market in 2025 with a 17.59% share, primarily due to the rising number of individuals undergoing eye surgeries and the rapid adoption of advanced ophthalmic diagnostic technologies.

Aberrometers and corneal topography systems are crucial in modern ophthalmology. An aberrometer measures optical aberrations in the eye, assessing imperfections in light refraction through the cornea and lens, affecting vision quality. Corneal topography provides detailed mapping of corneal curvature and shape, aiding in the diagnosis and management of various ocular conditions. The rising prevalence of visual impairments such as astigmatism, hyperopia, and cataracts has spurred demand for these advanced diagnostic solutions. According to NCBI, astigmatism affects 40% of adults globally, emphasizing the growing need for accurate eye diagnostics.

Market Dynamics

Drivers: The increasing incidence of ophthalmic diseases, driven by lifestyle changes, diabetes, and an aging population, is a major growth driver. Myopia is projected to affect 50% of the global population by 2050, highlighting the importance of early diagnosis using aberrometers and topography systems. Governments and healthcare providers are prioritizing preventive eye care, further boosting demand for diagnostic devices.

Restraints: The high cost of advanced devices, such as the Nidek OPD-Scan III Wavefront Aberrometer priced around USD 15,000 in 2025, limits adoption in developing regions. Additionally, limited awareness regarding routine eye exams in low- and middle-income countries reduces market penetration. WHO data indicates 2.2 billion people worldwide suffer from vision impairment, with 1 billion cases preventable, reflecting the awareness gap.

Opportunities: Strategic alliances and acquisitions among key players are creating opportunities for market expansion. For instance, Carl Zeiss Meditech AG acquired D.O.R.C. in April 2024, enhancing its portfolio of ophthalmic solutions. Partnerships facilitate the development of next-generation diagnostic tools, fueling product innovation and new launches.

Challenges: The shortage of trained ophthalmic professionals could hinder market growth. In the U.S., there were fewer than 60,000 ophthalmic technicians supporting over 19,000 ophthalmologists as of 2024, potentially limiting patient access to advanced diagnostic services.

Market Segmentation

By Type: The market is segmented into aberrometers and topography systems. The aberrometer segment dominates due to innovations like Hartmann-Shack and Ray-Tracing techniques. For example, Tracey Technologies launched iTrace Prime in February 2023, enhancing aberrometer and topographer functionalities. Topography systems, including Placido disc and Scheimpflug imaging, are also expanding with AI and IoT integration for improved diagnostics.

By Indication: Hyperopia, myopia, astigmatism, and others form the market indications. Hyperopia is projected to hold a significant share due to its prevalence in adults (30.9%) and children (4.6%). Myopia growth is driven by screen time and aging populations, while astigmatism benefits from advanced topography systems, such as the Cassini topographer, providing accurate corneal maps.

By End-User: Hospitals lead due to higher procedural volumes and access to advanced equipment, while ophthalmic clinics are projected to grow at the highest CAGR due to increasing availability of diagnostic solutions. Telehealth and academic clinics are emerging as significant contributors through strategic partnerships, such as Visionix and 20/20NOW in 2023, expanding tele-optometry services.

Regional Outlook

• North America: Largest market at USD 183.07 million in 2025, driven by high diabetes prevalence (38.4 million in the U.S.) and widespread adoption of advanced diagnostics.
• Europe: Significant share due to strong industry presence and skilled ophthalmologists (3,377 in the U.K. as of 2023).
• Asia Pacific: Expected highest CAGR with market expansion in Japan, China, and India. Strategic partnerships, like HAAG-STREIT GROUP and Gaush Medical in 2023, enhance regional availability.
• Latin America & Middle East/Africa: Growing markets due to increasing ophthalmologist numbers, healthcare infrastructure investments, and awareness campaigns.

Competitive Landscape

The market is consolidated with Carl Zeiss Meditech AG, Topcon Corporation, and Alcon Inc. holding the majority share. Companies focus on strategic alliances, acquisitions, and new product launches to expand their global presence. Other key players include NIDEK, Haag-Streit Group, EssilorLuxottica, Rexxam, Schwind eye-tech, and Mediworks. Notable developments include EssilorLuxottica acquiring 80% of Heidelberg Engineering in 2024 and Haag-Streit Japan K.K. launch in 2023.

Market Trends

Technological advancements are transforming the market, including dynamic wavefront aberrometry, multimodal topography, and portable devices for remote eye care. AI and IoT integration enhance diagnostic precision, workflow efficiency, and personalized patient care.

COVID-19 Impact

The pandemic caused a temporary decline in demand due to reduced patient visits and supply chain disruptions. Carl Zeiss Meditech AG reported a -7% sales decline in 2020. Post-2021, market recovery has been observed as patient visits increased.

Conclusion

The global aberrometer & topography systems market is poised for substantial growth from USD 501.24 million in 2025 to USD 836.73 million by 2034, driven by technological innovations, increasing prevalence of eye disorders, and strategic initiatives by market leaders. Despite challenges such as high device costs and skilled workforce shortages, the market presents significant opportunities across all regions, particularly in Asia Pacific, telehealth, and advanced diagnostic solutions.

Segmentation By Type

• Aberrometer
  • Hartmann-Shack Aberrometer
  • Tscherning Aberrometer
  • Ray-Tracing Aberrometer
• Topography Systems
  • Placido Disc Reflection System
  • Scheimpflug Imaging System
  • Scanning-Slit System

By Indication

• Hyperopia
• Myopia
• Astigmatism
• Others

By End-user

• Hospitals
• Ophthalmic Clinics
• Others

By Geography

• North America (By Type, Indication, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Type, Indication, End-user, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, Indication, End-user, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, Indication, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, Indication, End-user, and Country/Sub-region)
  • GCC
  • South Africa
  • Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Conditions, By Key Countries/Region, 2025
• 4.2. Overview of Regulatory Scenario
• 4.3. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)
• 4.4. New Product Launch/Approvals, By Key Players
• 4.5. Impact of COVID-19 on the Market

5. Global Aberrometer & Topography Systems Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Aberrometer
    • 5.1.1.1. Hartmann-Shack Aberrometer
    • 5.1.1.2. Tscherning Aberrometer
    • 5.1.1.3. Ray-Tracing Aberrometer
  • 5.1.2. Topography Systems
    • 5.1.2.1. Placido Disc Reflection System
    • 5.1.2.2. Scheimpflug Imaging System
    • 5.1.2.3. Scanning-Slit System
• 5.2. Market Analysis, Insights and Forecast - By Indication
  • 5.2.1. Hyperopia
  • 5.2.2. Myopia
  • 5.2.3. Astigmatism
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals
  • 5.3.2. Ophthalmic Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Aberrometer & Topography Systems Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Aberrometer
    • 6.1.1.1. Hartmann-Shack Aberrometer
    • 6.1.1.2. Tscherning Aberrometer
    • 6.1.1.3. Ray-Tracing Aberrometer
  • 6.1.2. Topography Systems
    • 6.1.2.1. Placido Disc Reflection System
    • 6.1.2.2. Scheimpflug Imaging System
    • 6.1.2.3. Scanning-Slit System
• 6.2. Market Analysis, Insights and Forecast - By Indication
  • 6.2.1. Hyperopia
  • 6.2.2. Myopia
  • 6.2.3. Astigmatism
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospitals
  • 6.3.2. Ophthalmic Clinics
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Aberrometer & Topography Systems Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Aberrometer
    • 7.1.1.1. Hartmann-Shack Aberrometer
    • 7.1.1.2. Tscherning Aberrometer
    • 7.1.1.3. Ray-Tracing Aberrometer
  • 7.1.2. Topography Systems
    • 7.1.2.1. Placido Disc Reflection System
    • 7.1.2.2. Scheimpflug Imaging System
    • 7.1.2.3. Scanning-Slit System
• 7.2. Market Analysis, Insights and Forecast - By Indication
  • 7.2.1. Hyperopia
  • 7.2.2. Myopia
  • 7.2.3. Astigmatism
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospitals
  • 7.3.2. Ophthalmic Clinics
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Aberrometer & Topography Systems Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Aberrometer
    • 8.1.1.1. Hartmann-Shack Aberrometer
    • 8.1.1.2. Tscherning Aberrometer
    • 8.1.1.3. Ray-Tracing Aberrometer
  • 8.1.2. Topography Systems
    • 8.1.2.1. Placido Disc Reflection System
    • 8.1.2.2. Scheimpflug Imaging System
    • 8.1.2.3. Scanning-Slit System
• 8.2. Market Analysis, Insights and Forecast - By Indication
  • 8.2.1. Hyperopia
  • 8.2.2. Myopia
  • 8.2.3. Astigmatism
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospitals
  • 8.3.2. Ophthalmic Clinics
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Aberrometer & Topography Systems Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Aberrometer
    • 9.1.1.1. Hartmann-Shack Aberrometer
    • 9.1.1.2. Tscherning Aberrometer
    • 9.1.1.3. Ray-Tracing Aberrometer
  • 9.1.2. Topography Systems
    • 9.1.2.1. Placido Disc Reflection System
    • 9.1.2.2. Scheimpflug Imaging System
    • 9.1.2.3. Scanning-Slit System
• 9.2. Market Analysis, Insights and Forecast - By Indication
  • 9.2.1. Hyperopia
  • 9.2.2. Myopia
  • 9.2.3. Astigmatism
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospitals
  • 9.3.2. Ophthalmic Clinics
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Aberrometer & Topography Systems Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Aberrometer
    • 10.1.1.1. Hartmann-Shack Aberrometer
    • 10.1.1.2. Tscherning Aberrometer
    • 10.1.1.3. Ray-Tracing Aberrometer
  • 10.1.2. Topography Systems
    • 10.1.2.1. Placido Disc Reflection System
    • 10.1.2.2. Scheimpflug Imaging System
    • 10.1.2.3. Scanning-Slit System
• 10.2. Market Analysis, Insights and Forecast - By Indication
  • 10.2.1. Hyperopia
  • 10.2.2. Myopia
  • 10.2.3. Astigmatism
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Hospitals
  • 10.3.2. Ophthalmic Clinics
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. EssilorLuxottica
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Carl Zeiss Meditech AG
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Topcon Corporation
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Alcon, Inc.
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. NIDEK CO., LTD.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Haag-Streit Group
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Rexxam Co., Ltd.
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Schwind eye-tech-solutions GmbH
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Mediworks
    • 11.2.9.1. Overview
    • 11.2.9.2. Products
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)